These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 23832448

  • 21. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX, Buddha H, Castelino-Prabhu S, Zhang Z, Britton RS, Bacon BR, Neuschwander-Tetri BA.
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [Abstract] [Full Text] [Related]

  • 22. Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β.
    Sakata K, Eda S, Lee ES, Hara M, Imoto M, Kojima S.
    Biochem Biophys Res Commun; 2014 Jan 17; 443(3):950-6. PubMed ID: 24361885
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Yoshida T, Akiba J, Matsui T, Nakamura K, Hisamoto T, Abe M, Ikezono Y, Wada F, Iwamoto H, Nakamura T, Koga H, Yamagishi SI, Torimura T.
    Dig Dis Sci; 2017 Jun 17; 62(6):1527-1536. PubMed ID: 28365916
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K.
    J Gastroenterol Hepatol; 2008 Dec 17; 23(12):1909-16. PubMed ID: 18422963
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways.
    Yong Q, Huang C, Chen B, An J, Zheng Y, Zhao L, Peng C, Liu F.
    Biomed Pharmacother; 2024 Aug 17; 177():116952. PubMed ID: 38917754
    [Abstract] [Full Text] [Related]

  • 31. N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis.
    Kamada Y, Mori K, Matsumoto H, Kiso S, Yoshida Y, Shinzaki S, Hiramatsu N, Ishii M, Moriwaki K, Kawada N, Takehara T, Miyoshi E.
    Glycobiology; 2012 Jun 17; 22(6):778-87. PubMed ID: 22294551
    [Abstract] [Full Text] [Related]

  • 32. Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells.
    Liu C, Chen X, Yang L, Kisseleva T, Brenner DA, Seki E.
    J Biol Chem; 2014 Mar 07; 289(10):7082-7091. PubMed ID: 24448807
    [Abstract] [Full Text] [Related]

  • 33. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.
    Li ZJ, Ou-Yang PH, Han XP.
    Cell Signal; 2014 Jan 07; 26(1):141-8. PubMed ID: 24100264
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.
    Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Tomizawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, Hibi T.
    Gut; 2006 Mar 07; 55(3):415-24. PubMed ID: 16174657
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
    Ma KL, Ruan XZ, Powis SH, Chen Y, Moorhead JF, Varghese Z.
    Transplantation; 2007 Oct 27; 84(8):1029-36. PubMed ID: 17989609
    [Abstract] [Full Text] [Related]

  • 38. Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2.
    Lee EH, Lee JH, Kim DY, Lee YS, Jo Y, Dao T, Kim KE, Song DK, Seo JH, Seo YK, Seong JK, Moon C, Han E, Kim MK, Ryu S, Shin M, Roh GS, Jung HR, Osborne TF, Ryu D, Jeon TI, Im SS.
    Exp Mol Med; 2024 Apr 27; 56(4):1001-1012. PubMed ID: 38622198
    [Abstract] [Full Text] [Related]

  • 39. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G, An P, Vaid KA, Nasser I, Huang P, Tan L, Zhao S, Schuppan D, Popov YV.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G174-G188. PubMed ID: 31630534
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.